Dr. Saima Zafar
is working as
Professor
in the
School of Mechanical & Manufacturing Engineering
. Dr. Saima Zafar
has a PhD in
Neuroscinces
. Dr. Saima Zafar
has published
73
research articles & conference papers having a citation count of
1470
, carried out
2
projects and filed
0
intellectual property.
Department of Clinical Chemistry, Universitätsmedizin Göttingen (UMG),
,
robert kock str 40 goettingen germany
,
Awards
University of the Punjab
2020
Merit Scholarship, University of the Punjab, Lahore,
Pakistan
HAI-IDR
2013
Research grant- Helmholtz-Alberta Initiative-Infectious
Diseases Research (HAI-IDR)
Human prions
2013
Research grant- Human prions – distinguishing sporadic
from familial forms via structure and function – 201300024
European Union
2011
Post-Doctoral fellowship, Protecting the food chain from
prions (Priority) European Union (EU) funded projects to
evaluate the epidemiology and surveillance of CJD
subtypes
UMG germany
2011
Post-Doctoral fellowship, DGKL-funding, “Kidney fibrosis
and Mycophenolic acid”
European Union (EU)
2007
Ph.D. fellowship, 6th framework European Union (EU)-
funded project, “Identification of potential biomarkers of
CJD using STrEPTM technology and proteomics”.
University of the Punjab
2004
Gold Medal, Role of Honor, M.Sc. Department of Zoology,
University of the Punjab, Lahore, Pakistan
University of the Punjab
2003
Gold Medal, Role of Honor, B.Sc (Hons.) Department of
Zoology, University of the Punjab, Lahore, Pakistan
Identification and characterization of Tau hyperphosphorylation role in the spread of tau pathology, an attractive therapeutic target in Alzheimer’s disease2021
3D Organoid Culture: In Vitro Models to decipher the Role of exosomal Tau in Alzheimer’s disease2023
KH
KHALID IQBAL
(Department of Neurochemistry, NYS Institute for Basic Research, Staten Island, New York and Professor of Neuroscience, The Graduate Center, The City University of New York, New York)
Journal: The Yale Journal of Biology and Medicine, Volume 97(2), Pages 153-164
Impact Factor: 2.500Citations: 4Quartile: 2
Prevention of Chronic Diabetic Neuropathy and Diabetes-Associated Cognitive Impairment Using Medicinal Herbs (Cassia Angustifolia and Nigella Sativa)2024
Stratification by genetic and demographic characteristics improves diagnostic accuracy of cerebrospinal fluid biomarkers in rapidly progressive dementia2016
AN
André Karch
(Helmholtz Centre for Infection Research)
FR
Franc Llorens
(University Medical School Gottingen)
MA
Matthias Schmitz
(University Medical School Gottingen)
AM
Amandeep Singh Arora
(University Medical School Gottingen)
Olivier Andréoletti
(National Veterinary School of Toulouse)
IN
Inga Zerr
(Georg-August University)
IS
Isidre Ferrer
(University of Barcelona)
Journal: Frontiers in Aging Neuroscience, Volume 6, Article Number 198
Impact Factor: 4.000Citations: 65Quartile: 1
Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases2014
Emma Jones
(Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK)
HO
Holger Hummerich
(Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK)
EM
Emmanuelle Viré
(Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK)
JA
James Uphill
(Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK)
AT
Athanasios Dimitriadis
(Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK)
PR
Prof Simon Mead
(Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK)
HE
Helen Speedy
(Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK)
TR
Tracy Campbell
(Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK)
P
Penny Norsworthy
(Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK)
L
Liam Quinn
(Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK)
JE
Jerome Whitfield
(Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK)
JA
Jacqueline Linehan
(Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK)
ZA
Zane Jaunmuktane
(Division of Neuropathology, University College London Hospitals National Health Service Foundation Trust, London, UK; Department of Clinical and Movement Neurosciences and Queen Square Brain Bank for Neurological Disorders, University College London Queen)
SE
Sebastian Brandner
(Division of Neuropathology, University College London Hospitals National Health Service Foundation Trust, London, UK; Department of Neurodegenerative Disease, University College London Queen Square Institute of Neurology, London, UK.)
PA
Parmjit Jat
(Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK)
AK
Akin Nihat
(Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK; National Prion Clinic, University College London Hospitals National Health Service Foundation Trust, London, UK.)
TZ
Tze How Mok
(Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK; National Prion Clinic, University College London Hospitals National Health Service Foundation Trust, London, UK.)
PA
Parvin Ahmed
(Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK.)
ST
Steven Collins
(Australian National Creutzfeldt-Jakob Disease Registry, Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC, Australia.)
CH
Christiane Stehmann
(Australian National Creutzfeldt-Jakob Disease Registry, Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC, Australia.)
SH
Shannon Sarros
(Australian National Creutzfeldt-Jakob Disease Registry, Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC, Australia.)
GA
Gabor G Kovacs
(Institute of Neurology, Medical University of Vienna, Vienna, Austria; Department of Laboratory Medicine and Pathobiology and Tanz Centre for Research in Neurodegenerative Disease, University of Toronto, Toronto, ON, Canada; Laboratory Medicine Program, K)
M
Michael D Geschwind
(University of California San Francisco Memory and Aging Center, Department of Neurology, University of California, San Francisco, CA, USA.)
AI
Aili Golubjatniko
(University of California San Francisco Memory and Aging Center, Department of Neurology, University of California, San Francisco, CA, USA.)
K
Karl Frontzek
(Institute of Neuropathology, University of Zurich, Zurich, Switzerland.)
HE
Herbert Budka
(Institute of Neuropathology, University of Zurich, Zurich, Switzerland; Medical University Vienna, Vienna, Austria.)
AD
Adriano Aguzzi
(Institute of Neuropathology, University of Zurich, Zurich, Switzerland.)
HA
Hata Karamuji?-?omi?
(Department of Epidemiology, Erasmus Medical Centre, Rotterdam, Netherlands.)
SV
Sven J van der Lee
(Department of Epidemiology, Erasmus Medical Centre, Rotterdam, Netherlands.)
CA
Carla A Ibrahim-Verbaas
(Department of Epidemiology, Erasmus Medical Centre, Rotterdam, Netherlands.)
CO
Cornelia M van Duijn
(Department of Epidemiology, Erasmus Medical Centre, Rotterdam, Netherlands; Nuffield Department of Population Health, University of Oxford, Oxford, UK.)
BE
Beata Sikorska
(Department of Molecular Pathology and Neuropathology, Medical University of Lodz, Lodz, Poland)
EW
Ewa Golanska
(Department of Molecular Pathology and Neuropathology, Medical University of Lodz, Lodz, Poland)
PA
Pawel P Liberski
(Department of Molecular Pathology and Neuropathology, Medical University of Lodz, Lodz, Poland)
MI
Miguel Calero
(Chronic Disease Programme (UFIEC-CROSADIS) and Network Centre for Biomedical Research in Neurodegenerative Diseases (CIBERNED), and Alzheimer Disease Research Unit, CIEN Foundation, Queen Sofia Foundation Alzheimer Centre, Instituto de Salud Carlos III, M)
OL
Olga Calero
(Chronic Disease Programme (UFIEC-CROSADIS) and Network Centre for Biomedical Research in Neurodegenerative Diseases (CIBERNED), and Alzheimer Disease Research Unit, CIEN Foundation, Queen Sofia Foundation Alzheimer Centre, Instituto de Salud Carlos III, M)
PA
Pascual Sanchez-Juan
(Neurology Service, University Hospital Marqués de Valdecilla, University of Cantabria, CIBERNED and IDIVAL, Santander, Spain.)
PA
Pascual Sanchez-Juan
(Neurology Service, University Hospital Marqués de Valdecilla, University of Cantabria, CIBERNED and IDIVAL, Santander, Spain.)
AN
Antonio Salas
(Unidade de Xenética, Instituto de Ciencias Forenses (INCIFOR), Facultade de Medicina, Universidade de Santiago de Compostela, and GenPoB Research Group, Instituto de Investigaciones Sanitarias (IDIS), Hospital Clínico Universitario de Santiago (SERGAS), G)
FE
Federico Martinón-Torres
(Translational Paediatrics and Infectious Diseases, Department of Paediatrics, Hospital Clínico Universitario de Santiago de Compostela, Galicia, Spain.)
EL
Elodie Bouaziz-Amar
(Department of Biochemistry and Molecular Biology, Lariboisière Hospital, AP-HP, University of Paris, Paris, France.)
ST
Stéphane Haïk
(Sorbonne Université, INSERM U1127, CNRS UMR 7225, Institut du Cerveau et de la Moelle épinière, Paris, France; Cellule nationale de référence des maladies de Creutzfeldt-Jakob, AP-HP, University Hospital Pitié-Salpêtrière, Paris, France.)
JE
Jean-Louis Laplanche
(Department of Biochemistry and Molecular Biology, Lariboisière Hospital, AP-HP, University of Paris, Paris, France.)
JE
Jean-Phillipe Brandel
(Sorbonne Université, INSERM U1127, CNRS UMR 7225, Institut du Cerveau et de la Moelle épinière, Paris, France; Cellule nationale de référence des maladies de Creutzfeldt-Jakob, AP-HP, University Hospital Pitié-Salpêtrière, Paris, France.)
PH
Phillipe Amouyel
(INSERM, CHU Lille, Institut Pasteur de Lille, U1167-RID-AGE, Labex DISTALZ, University of Lille, Lille, France.)
JE
Jean-Charles Lambert
(iNSERM, CHU Lille, Institut Pasteur de Lille, U1167-RID-AGE, Labex DISTALZ, University of Lille, Lille, France.)
PI
Piero Parchi
(IRCCS, Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy; Department of Experimental, Diagnostic, and Specialty Medicine, University of Bologna, Bologna, Italy.)
AN
Anna Bartoletti-Stella
(IRCCS, Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.)
SA
Sabina Capellari
(IRCCS, Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy; Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.)
A
Anna Poleggi
(Department of Neuroscience, Istituto Superiore di Sanità, Rome, Italy.)
MA
Maurizio Pocchiari
(Department of Neuroscience, Istituto Superiore di Sanità, Rome, Italy.)
S
Serena Aneli
(Department of Medical Sciences, Università degli studi di Torino, Torino, Italy.)
GI
Giuseppe Matullo
(Department of Medical Sciences, Università degli studi di Torino, Torino, Italy.)
KA
Katie Glisic
(Departments of Pathology and Neurology, Case Western Reserve University, Cleveland, OH, USA; National Prion Disease Pathology Surveillance Center, Case Western Reserve University, Cleveland, OH, USA.)
IN
Inga Zerr
(Department of Neurology, Clinical Dementia Centre and National Reference Centre for Creutzfeldt-Jakob Disease Surveillance, University Medical School, Göttingen, Germany; German Centre for Neurodegenerative Diseases (DZNE), Göttingen, Germany.)
BR
Brian Appleby
(Departments of Pathology and Neurology, Case Western Reserve University, Cleveland, OH, USA; National Prion Disease Pathology Surveillance Center, Case Western Reserve University, Cleveland, OH, USA.)
P
Pierluigi Gambetti
(Departments of Pathology and Neurology, Case Western Reserve University, Cleveland, OH, USA; National Prion Disease Pathology Surveillance Center, Case Western Reserve University, Cleveland, OH, USA.)
GE
Gerard H Jansen
(Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, ON, Canada.)
JI
Jiri Safar
(Departments of Pathology and Neurology, Case Western Reserve University, Cleveland, OH, USA; National Prion Disease Pathology Surveillance Center, Case Western Reserve University, Cleveland, OH, USA.)
JO
John Collinge
(Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK; National Prion Clinic, University College London Hospitals National Health Service Foundation Trust, London, UK.)
Matthias Schmitz
(University Medical Center Göttingen)
AN
Anna Villar-Piqué
(Bellvitge Biomedical Research Institute)
Journal: Frontiers in Bioengineering and Biotechnology, Volume 8, Article Number 586890
Impact Factor: 5.890Citations: 6Quartile: 1
Regional and subtype-dependent miRNA signatures in sporadic Creutzfeldt-Jakob disease are accompanied by alterations in miRNA silencing machinery and biogenesis2018
FR
Franc Llorens
(University Medical School)
K
Katrin Thüne
(University Medical Center Gottingen)
EU
Eulàlia Martí
(Centre for Genomic Regulation)
DI
Dimitra Dafou
(Aristotle University of Thessaloniki)
AN
Ana Vivancos
(Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain)
OR
Orr Shomroni
(VHIO Vall d'Hebron Institute of Oncology)
